U.S. Veterinary Oncology Diagnostics Market (2025 - 2030) Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Test Type (Biopsy, Genome Testing), By Cancer Type (Skin Cancers, Sarcomas), By End Use, By Country, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation and Scope
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased Database
                       1.3.2. GVR’s Internal Database
                       1.3.3. Secondary Sources
                       1.3.4. Primary Research
                   1.4. Information/Data Analysis
                   1.5. Market Formulation & Visualization
                   1.6. Data Validation & Publishing
                   1.7. Model Details
                       1.7.1. Commodity flow analysis
                       1.7.2. Global Market: CAGR Calculation
                   1.8. List of Secondary Sources
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                   2.3. Competitive Insights
Chapter 3. U.S. Veterinary Oncology Diagnostics Market Variable Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent Market
                       3.1.2. Ancillary Market
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                           3.2.1.1. Increasing prevalence of cancer in pets
                           3.2.1.2. Increasing R&D in veterinary oncolgy diagnostics
                           3.2.1.3. Growing focus on animal safety
                           3.2.1.4. Growing uptake of pet insurance
                           3.2.1.5. Technological advancements in early pet cancer diagnosis
                           3.2.1.6. Increase in pet population
                       3.2.2. Market Restraint Analysis
                           3.2.2.1. High cost of veterinary oncology diagnostics
                           3.2.2.2. Lack of awareness in developing countries
                       3.2.3. Market Opportunity Analysis
                       3.2.4. Market Challenge Analysis
                   3.3. U.S. Veterinary Oncology Diagnostics Market Analysis Tools
                       3.3.1. Industry Analysis – Porter’s
                           3.3.1.1. Bargaining power of suppliers
                           3.3.1.2. Bargaining power of buyers
                           3.3.1.3. Threat of substitution
                           3.3.1.4. Threat of new entrants
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political & Legal Landscape
                           3.3.2.2. Economic and Social Landscape
                           3.3.2.3. Technological landscape
                           3.3.2.4. Environmental Landscape
                       3.3.3. Regulatory Framework
                       3.3.4. Estimated Animal Population, by Key Species, 2018 - 2024
                       3.3.5. COVID-19 Impact Analysis
Chapter 4. U.S. Veterinary Oncology Diagnostics Market: Animal Type Estimates & Trend Analysis
                   4.1. Segment Dashboard
                   4.2. U.S. Veterinary Oncology Diagnostics Market Animal Type Movement Analysis
                   4.3. U.S. Veterinary Oncology Diagnostics Market Size & Trend Analysis, By Animal Type, 2018 - 2030 (USD Million)
                       4.3.1. Canine
                           4.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.3.2. Feline
                           4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.3.3. Others
                           4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Veterinary Oncology Diagnostics Market: Test Type Estimates & Trend Analysis
                   5.1. Segment Dashboard
                   5.2. U.S. Veterinary Oncology Diagnostics Market Test Type Movement Analysis
                   5.3. U.S. Veterinary Oncology Diagnostics Market Size & Trend Analysis, By Test Type 2018 - 2030 (USD Million)
                       5.3.1. Blood Tests
                           5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.3.2. Biopsy
                           5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.3.3. Genome testing
                           5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.3.4. Endoscopy
                           5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.3.5. Urinalysis
                           5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.3.6. Imaging
                           5.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Veterinary Oncology Diagnostics Market: Cancer Type Estimates & Trend Analysis
                   6.1. Segment Dashboard
                   6.2. U.S. Veterinary Oncology Diagnostics Market Cancer Type Movement Analysis
                   6.3. U.S. Veterinary Oncology Diagnostics Market Size & Trend Analysis, By Cancer Type, 2018 - 2030 (USD Million)
                       6.3.1. Lymphoma
                           6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.3.2. Sarcomas
                           6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.3.3. Mammary Gland Tumors
                           6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.3.4. Skin Cancers
                           6.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.3.5. Others
                           6.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. U.S. Veterinary Oncology Diagnostics Market: End Use Estimates & Trend Analysis
                   7.1. Segment Dashboard
                   7.2. U.S. Veterinary Oncology Diagnostics Market End-Use Movement Analysis
                   7.3. U.S. Veterinary Oncology Diagnostics Market Size & Trend Analysis, By End-Use 2018 - 2030 (USD Million)
                       7.3.1. Reference Laboratories
                           7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                       7.3.2. Veterinary hospitals and clinics
                           7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
                   8.1. Market Participant Categorization
                   8.2. Participants Overview
                   8.3. Financial Performance
                   8.4. Product Benchmarking
                   8.5. Market Position Analysis, 2024 (Heat Map Analysis)
                   8.6. Strategy Mapping
                       8.6.1. Mergers and Acquisitions
                       8.6.2. Launch
                       8.6.3. Partnerships & Collaborations
                       8.6.4. Expansion
                       8.6.5. Others
                   8.7. Company Profiles
                       8.7.1. Zoetis
                           8.7.1.1. Participant’s overview
                           8.7.1.2. Financial performance
                           8.7.1.3. Product Benchmarking
                           8.7.1.4. Strategic initiatives
                       8.7.2. Antech Diagnostics, Inc. (Mars Inc.)
                           8.7.2.1. Participant’s overview
                           8.7.2.2. Financial performance
                           8.7.2.3. Product Benchmarking
                           8.7.2.4. Strategic initiatives
                       8.7.3. IDEXX Laboratories, Inc.
                           8.7.3.1. Participant’s overview
                           8.7.3.2. Financial performance
                           8.7.3.3. Product Benchmarking
                           8.7.3.4. Strategic initiatives
                       8.7.4. Neogen Corporation
                           8.7.4.1. Participant’s overview
                           8.7.4.2. Financial performance
                           8.7.4.3. Product Benchmarking
                           8.7.4.4. Strategic initiatives
                       8.7.5. Gold Standard Diagnostics (Eurofins Technologies)
                           8.7.5.1. Participant’s overview
                           8.7.5.2. Financial performance
                           8.7.5.3. Product Benchmarking
                           8.7.5.4. Strategic initiatives
                       8.7.6. Embark Veterinary, Inc.
                           8.7.6.1. Participant’s overview
                           8.7.6.2. Financial performance
                           8.7.6.3. Product Benchmarking
                           8.7.6.4. Strategic initiatives
                       8.7.7. VolitionRx Limited
                           8.7.7.1. Participant’s overview
                           8.7.7.2. Financial performance
                           8.7.7.3. Product Benchmarking
                           8.7.7.4. Strategic initiatives
                       8.7.8. CANCAN DIAGNOSTICS
                           8.7.8.1. Participant’s overview
                           8.7.8.2. Financial performance
                           8.7.8.3. Product Benchmarking
                           8.7.8.4. Strategic initiatives
                       8.7.9. Oncotect
                           8.7.9.1. Participant’s overview
                           8.7.9.2. Financial performance
                           8.7.9.3. Product Benchmarking
                           8.7.9.4. Strategic initiatives
                       8.7.10. PetDx
                           8.7.10.1. Participant’s overview
                           8.7.10.2. Financial performance
                           8.7.10.3. Product Benchmarking
                           8.7.10.4. Strategic initiatives

List of Tables

Table. 1 List of Secondary Sources
Table. 2 List of Abbreviations
Table. 3 U.S. veterinary oncology diagnostics market, by Animal, 2018 - 2030 (USD Million)
Table. 4 U.S. veterinary oncology diagnostics market, by Test Type, 2018 - 2030 (USD Million)
Table. 5 U.S. veterinary oncology diagnostics market, by Cancer Type, 2018 - 2030 (USD Million)
Table. 6 U.S. veterinary oncology diagnostics market, by End-Use, 2018 - 2030 (USD Million)
Table. 7 Company Overview
Table. 8 Service Benchmarking
Table. 9 Financial Performance
Table. 10 Strategic Initiatives 

List of Figures

Fig. 1 U.S. veterinary oncology diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Data Analysis Models
Fig. 6 Market Formulation And Validation
Fig. 7 Data Validating & Publishing
Fig. 8 General methodology for a commodity flow analysis of U.S. veterinary oncology diagnostics market
Fig. 9 Commodity flow analysis
Fig. 10 Parent market analysis
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Segment snapshot
Fig. 14 Competitive landscape snapshot
Fig. 15 Parent market value, 2024 (USD Billion)
Fig. 16 Ancillary market outlook, 2024
Fig. 17 U.S. veterinary oncology diagnostics market Dynamics
Fig. 18 Estimated animal population, 2018 - 2024 by key species
Fig. 19 U.S. veterinary oncology diagnostics market: PORTER’s analysis
Fig. 20 U.S. veterinary oncology diagnostics market: PESTEL analysis
Fig. 21 U.S. veterinary oncology diagnostics market by Animal: Key Takeaways
Fig. 22 U.S. veterinary oncology diagnostics market by Animal, 2024 & 2030
Fig. 23 Canine market, 2018 - 2030 (USD Million)
Fig. 24 Feline market, 2018 - 2030 (USD Million)
Fig. 25 Others market, 2018 - 2030 (USD Million)
Fig. 26 U.S. veterinary oncology diagnostics market by Test Type: Key Takeaways
Fig. 27 U.S. veterinary oncology diagnostics market by Test Type, Market Share, 2024 & 2030
Fig. 28 Blood Tests market, 2018 - 2030 (USD Million)
Fig. 29 Biopsy market, 2018 - 2030 (USD Million)
Fig. 30 Genome testing market, 2018 - 2030 (USD Million)
Fig. 31 Endoscopy market, 2018 - 2030 (USD Million)
Fig. 32 Urinalysis market, 2018 - 2030 (USD Million)
Fig. 33 Imaging market, 2018 - 2030 (USD Million)
Fig. 34 U.S. veterinary oncology diagnostics market by Cancer Type: Key Takeaways
Fig. 35 U.S. veterinary oncology diagnostics market by Cancer Type, Market Share, 2024 & 2030
Fig. 36 Lymphoma market, 2018 - 2030 (USD Million)
Fig. 37 Sarcomas market, 2018 - 2030 (USD Million)
Fig. 38 Mammary Gland Tumors market, 2018 - 2030 (USD Million)
Fig. 39 Skin Cancers market, 2018 - 2030 (USD Million)
Fig. 40 Others market, 2018 - 2030 (USD Million)
Fig. 41 U.S. veterinary oncology diagnostics market by End-Use: Key Takeaways
Fig. 42 U.S. veterinary oncology diagnostics market by End-Use, Market Share, 2024 & 2030
Fig. 43 Reference Laboratories market, 2018 - 2030 (USD Million)
Fig. 44 Veterinary hospitals and clinics market, 2018 - 2030 (USD Million)
Fig. 45 Market Participant Categorization
Fig. 46 Heat map analysis
Fig. 47 Strategic Framework